USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 146 filers reported holding USANA HEALTH SCIENCES INC in Q2 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $482,000 | -84.8% | 6,251 | -85.5% | 0.76% | -17.6% |
Q3 2020 | $3,165,000 | -26.1% | 42,970 | -26.3% | 0.93% | +30.2% |
Q2 2020 | $4,281,000 | +30.2% | 58,294 | +2.4% | 0.71% | +107.0% |
Q1 2020 | $3,289,000 | +161.7% | 56,939 | +255.9% | 0.34% | +194.0% |
Q4 2019 | $1,257,000 | -74.5% | 16,000 | -74.2% | 0.12% | -69.7% |
Q2 2019 | $4,920,000 | -32.6% | 61,947 | -28.8% | 0.39% | -30.8% |
Q1 2019 | $7,296,000 | +10.8% | 86,996 | +55.5% | 0.56% | +8.8% |
Q4 2018 | $6,585,000 | +12.1% | 55,930 | +14.7% | 0.51% | +21.6% |
Q3 2018 | $5,876,000 | -8.5% | 48,741 | -12.4% | 0.42% | -9.1% |
Q2 2018 | $6,419,000 | +991.7% | 55,672 | +506.8% | 0.46% | +979.1% |
Q2 2017 | $588,000 | -84.2% | 9,174 | -65.9% | 0.04% | -84.0% |
Q3 2016 | $3,726,000 | -68.8% | 26,937 | -69.7% | 0.27% | -68.2% |
Q3 2015 | $11,931,000 | +3299.1% | 89,018 | +3363.7% | 0.85% | +3157.7% |
Q2 2015 | $351,000 | -95.6% | 2,570 | -96.7% | 0.03% | -95.1% |
Q4 2014 | $8,026,000 | – | 78,238 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
RQSI Ltd | 3,937 | $404,000 | 0.38% |
CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |